(Q39153274)

9 September 2017

title

Met-induced membrane blebbing leads to amoeboid cell motility and invasion (English)

1 reference

9 September 2017

A Laser-Azogui

1

1 reference

9 September 2017

T Diamant-Levi

2

1 reference

9 September 2017

S Israeli

3

1 reference

9 September 2017

Y Roytman

4

1 reference

9 September 2017

I Tsarfaty

5

1 reference

9 September 2017

language of work or name

English

0 references

publication date

13 May 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

33

1 reference

9 September 2017

issue

14

1 reference

9 September 2017

page(s)

1788-1798

1 reference

Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFkappa B

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Targeting MET in cancer: rationale and progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

MET: a promising anticancer therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Progress in cancer therapy targeting c-Met signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Tumour-cell invasion and migration: diversity and escape mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Dissection of amoeboid movement into two mechanically distinct modes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

SH4-domain-induced plasma membrane dynamization promotes bleb-associated cell motility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Reassembly of contractile actin cortex in cell blebs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Loss of p53 promotes RhoA-ROCK-dependent cell migration and invasion in 3D matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Positive feedback between Dia1, LARG, and RhoA regulates cell morphology and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Rho overexpression leads to mitosis-associated detachment of cells from epithelial sheets: a link to the mechanism of cancer dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Purification and characterization of beta-actin-rich tumor cell pseudopodia: role of glycolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Autocrine activation of the hepatocyte growth factor receptor/met tyrosine kinase induces tumor cell motility by regulating pseudopodial protrusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Rho/ROCK-dependent pseudopodial protrusion and cellular blebbing are regulated by p38 MAPK in tumour cells exhibiting autocrine c-Met activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

In vivo direct molecular imaging of early tumorigenesis and malignant progression induced by transgenic expression of GFP-Met

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

The mutationally activated Met receptor mediates motility and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: modeling studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Hepatocyte growth factor, its receptor, and their potential value in cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Life and times of a cellular bleb

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Actin polymerization and intracellular solvent flow in cell surface blebbing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Single-molecule microscopy reveals plasma membrane microdomains created by protein-protein networks that exclude or trap signaling molecules in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Plasma membrane microdomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Dorsal ruffle microdomains potentiate Met receptor tyrosine kinase signaling and down-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

The Gab1 scaffold regulates RTK-dependent dorsal ruffle formation through the adaptor Nck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Actin restricts FcepsilonRI diffusion and facilitates antigen-induced receptor immobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Silencing the MET oncogene leads to regression of experimental tumors and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Dysregulation of Met receptor tyrosine kinase activity in invasive tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Protrusive activity quantitatively determines the rate and direction of cell locomotion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Hepatocyte growth factor inhibits anoikis by induction of activator protein 1-dependent cyclooxygenase-2. Implication in head and neck squamous cell carcinoma progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

Differential regulation of Src-family protein tyrosine kinases in GPI domains of T lymphocyte plasma membranes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.138

31 March 2020

Identifiers

DOI

10.1038/ONC.2013.138

1 reference

9 September 2017

1 reference